Patent · US Expired

Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals

US8389497B2 · kind B2 · utility

0Cited by

7References

5Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Jurgen Engel · Alzenau, DE
Eckhard Gunther · Offenbach, DE
Herbert Sindermann · Rodgau, DE

Key dates

Filing date	Jul 30, 2003
Grant date	Mar 5, 2013
Priority date	—
Expiry date	Jul 30, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals. It is possible in this connection for the alkylphosphocholines to be employed in a combination according to the invention with one or a combination of various approved cytostatics. Preferred alkylphosphocholines are described by the Formula II.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.